Resultado de búsqueda
Hace 3 días · Entretanto, las bioquímicas Emmanuelle Charpentier (francesa) y Jennifer Doudna (estadounidense), desarrollaron, a partir de la bacteria Streptococcus pyogenes, el CRISPR/Cas9, un método que permite editar el genoma y, de este modo, avanzar en la búsqueda de la cura de diversas enfermedades hereditarias.
Hace 2 días · Un total de 48 candidaturas de 17 nacionalidades optan al Premio Princesa de Asturias de Investigación Científica y ... 2022), las bioquímicas Emmanuelle Charpentier y Jennifer Doudna, ...
Hace 4 días · The 2020 Nobel Prize in Chemistry was awarded to Jennifer Doudna and Emmanuelle Charpentier for developing a groundbreaking yet simple way to edit DNA, the "blueprint" of living organisms.
Hace 1 día · Un total de 48 candidaturas de 17 nacionalidades optan al Premio Princesa de Asturias de Investigación Científica y ... 2022), las bioquímicas Emmanuelle Charpentier y Jennifer Doudna, ...
Hace 1 día · Historia y Descubrimiento. CRISPR/Cas9’s beginning was in the defense mechanisms of tiny organisms. The brilliant findings of Jennifer Doudna and Emmanuelle Charpentier won them the Nobel Prize in 2020. Their work has shaped the use of CRISPR/Cas9 in correcting genes, bringing hope for powerful gene therapies.
Hace 3 días · Jennifer Doudna and Emmanuelle Charpentier won the 2020 Nobel Prize in Chemistry for creating a novel yet straightforward method of editing DNA, the “blueprint” of living things. While their discovery opened new avenues for research, concerns about the accuracy of the method and the safety of cutting both strands of DNA limited its use in gene therapy treatments.
Hace 4 días · This approach is an adaptive immune system that naturally protects bacteria from DNA virus infections and for this work two of its authors, Jennifer Doudna and Emmanuelle Charpentier, were awarded the Nobel Prize in Chemistry in 2020 (Jinek et al., Citation 2012).
